Literature DB >> 32735199

Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative.

Erika G Martin1,2, Roderick H MacDonald3, Daniel E Gordon4, Carol-Ann Swain4, Travis O'Donnell4, John Helmeset4, Adenantera Dwicaksono1,5, James M Tesoriero2,4.   

Abstract

OBJECTIVES: In 2014, the governor of New York announced the Ending the Epidemic (ETE) plan to reduce annual new HIV infections from 3000 to 750, achieve a first-ever decrease in HIV prevalence, and reduce AIDS progression by the end of 2020. The state health department undertook participatory simulation modeling to develop a baseline for comparing epidemic trends and feedback on ETE strategies.
METHODS: A dynamic compartmental model projected the individual and combined effects of 3 ETE initiatives: enhanced linkage to and retention in HIV treatment, increased preexposure prophylaxis (PrEP) among men who have sex with men, and expanded housing assistance. Data inputs for model calibration and low-, medium-, and high-implementation scenarios (stakeholders' rollout predictions, and lower and upper bounds) came from surveillance and program data through 2014, the literature, and expert judgment.
RESULTS: Without ETE (baseline scenario), new HIV infections would decline but remain >750, and HIV prevalence would continue to increase by 2020. Concurrently implementing the 3 programs would lower annual new HIV infections by 16.0%, 28.1%, and 45.7% compared with baseline in the low-, medium-, and high-implementation scenarios, respectively. In all concurrent implementation scenarios, although annual new HIV infections would remain >750, there would be fewer new HIV infections than deaths, yielding the first-ever decrease in HIV prevalence. PrEP and enhanced linkage and retention would confer the largest population-level changes.
CONCLUSIONS: New York State will achieve 1 ETE benchmark under the most realistic (medium) implementation scenario. Findings facilitated framing of ETE goals and underscored the need to prioritize men who have sex with men and maintain ETE's multipronged approach, including other programs not modeled here.

Entities:  

Keywords:  HIV; computer simulation; health policy; preexposure prophylaxis

Mesh:

Substances:

Year:  2020        PMID: 32735199      PMCID: PMC7407049          DOI: 10.1177/0033354920935069

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  38 in total

1.  Getting to Zero San Francisco: A Collective Impact Approach.

Authors:  Susan P Buchbinder; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12       Impact factor: 3.731

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  Effects of Reaching National Goals on HIV Incidence, by Race and Ethnicity, in the United States.

Authors:  Evin Uzun Jacobson; Katherine A Hicks; Emily L Tucker; Paul G Farnham; Stephanie L Sansom
Journal:  J Public Health Manag Pract       Date:  2018 Jul/Aug

4.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.

Authors:  Lisa A Grohskopf; Kata L Chillag; Roman Gvetadze; Albert Y Liu; Melanie Thompson; Kenneth H Mayer; Brandi M Collins; Sonal R Pathak; Brandon Oʼhara; Marta L Ackers; Charles E Rose; Robert M Grant; Lynn A Paxton; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

6.  Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.

Authors:  Ume L Abbas; Robert Glaubius; Anuj Mubayi; Gregory Hood; John W Mellors
Journal:  J Infect Dis       Date:  2013-04-09       Impact factor: 5.226

7.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

8.  Improving Retention in HIV Care Through New York's Expanded Partner Services Data-to-Care Pilot.

Authors:  James M Tesoriero; Britney L Johnson; Rachel Hart-Malloy; Jennifer L Cukrovany; Brenda L Moncur; Kathleen M Bogucki; Bridget J Anderson; Megan C Johnson
Journal:  J Public Health Manag Pract       Date:  2017 May/Jun

9.  Modelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa.

Authors:  N N Abuelezam; A W McCormick; E D Surface; T Fussell; K A Freedberg; M Lipsitch; G R Seage
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

10.  Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.

Authors:  Cora L Bernard; Douglas K Owens; Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  PLoS Med       Date:  2017-05-24       Impact factor: 11.613

View more
  2 in total

1.  Policy and Public Health : Reducing the Burden of Infectious Diseases.

Authors:  Deron C Burton; Scott Burris; Jonathan H Mermin; David W Purcell; Sara C Zeigler; Lara Bull-Otterson; Hazel D Dean
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

2.  Evaluation of Trends in Preexposure Prophylaxis Prescriptions During the First 6 Months of the COVID-19 Pandemic in New York State.

Authors:  Thomas J O'Grady; James M Tesoriero; Yingchao Yuan; Thomas M Grisham; Seung Jun Seo; Charles J Gonzalez; Johanne E Morne
Journal:  JAMA Netw Open       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.